About EthOss Regeneration
EthOss Regeneration is a company based in Silsden (United Kingdom) founded in 2013 by Peter Fairbairn was acquired by Lifco in February 2026. It operates as a B2B. EthOss Regeneration offers products and services including EthOss Bone Graft. EthOss Regeneration operates in a competitive market with competitors including Theradaptive, MiMedx Group, Ossio, RevBio and Aziyo Biologics, among others.
- Headquarter Silsden, United Kingdom
- Founders Peter Fairbairn
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Ethoss Regeneration Ltd
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of EthOss Regeneration
EthOss Regeneration offers a comprehensive portfolio of products and services, including EthOss Bone Graft.
Synthetic material for bone regeneration in dental implant procedures
Funding Insights of EthOss Regeneration
Detailed funding history for EthOss Regeneration
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in EthOss Regeneration
EthOss Regeneration has secured backing from 1 investor. Prominent investors backing the company include Lifco.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Dental equipment and supplies are distributed by Lifco in Sweden.
|
Locked | Locked | Locked |
Investor details for EthOss Regeneration
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by EthOss Regeneration
Investment portfolio details for EthOss Regeneration
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - EthOss Regeneration
Detailed financials for EthOss Regeneration
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Ethoss Regeneration Comparisons
Peer comparison for EthOss Regeneration
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of EthOss Regeneration
EthOss Regeneration operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Theradaptive, MiMedx Group, Ossio, RevBio and Aziyo Biologics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Therapeutic delivery platform is developed for orthopedic clinical indications.
|
|
| Locked | Locked | Locked |
Regenerative biomaterial products and bioimplants for wound, surgical, sports medicine and orthopedics
|
|
| Locked | Locked | Locked |
Orthopedic fixation is enabled by bone regeneration biocomposite technology.
|
|
| Locked | Locked | Locked |
Synthetic adhesives for bone and dental repair are developed.
|
|
| Locked | Locked | Locked |
Regenerative medicine products are developed for orthopedic and cardiovascular applications.
|
|
| Locked | Locked | Locked |
Developer of stem cells to regrow damaged bones
|
Detailed competitors of EthOss Regeneration
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Ethoss Regeneration
Complete news archive for EthOss Regeneration
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about EthOss Regeneration
EthOss Regeneration was founded in 2013.
EthOss Regeneration is headquartered in Silsden, United Kingdom.
EthOss is a synthetic bone graft material designed for dental implant surgery, working by creating a calcium-rich environment that supports the bodys natural healing process for bone regeneration. It eliminates the need for donor grafts or additional membranes, making procedures simpler and faster. Based in the United Kingdom, it serves clinicians worldwide, including in Australia and New Zealand, for applications like socket grafting and sinus augmentations, ensuring predictable and safe results with no residual particles.
EthOss Regeneration's top competitors include EpiBone, Theradaptive and MiMedx Group.
EthOss Regeneration offers EthOss Bone Graft.
EthOss Regeneration has 1 investor. Key investors include Lifco.